Advertisement Pharmaceutical Business review - Page 303 of 5221 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 17, 2024

MinervaX collaborates with Wacker Biotech for GBS vaccine production

MinervaX, a Danish biotechnology company, has joined forces with contract development and manufacturing organisation (CDMO) Wacker Biotech for the manufacturing of MinervaX’s active protein ingredients for its Group B Streptococcus (GBS) vaccine.

Continue
Wacker Biotech will be responsible for manufacturing MinervaX’s active protein ingredients for Group B Streptococcus (GBS) vaccine. Credit: Triggermouse from Pixabay.
September 16, 2024

Novavax announces availability of Covid-19 vaccine in US pharmacies

The authorisation allows for the distribution of the updated vaccine. Credit: Diana Polekhina on Unsplash.
September 13, 2024

China NMPA approves Keymed Biosciences’ Stapokibart for atopic dermatitis

The approval is based on results from a Phase III trial of the asset in moderate-to-severe atopic dermatitis patients. Credit: freestocks on Unsplash.

Contracts

August 9, 2024

Bavarian Nordic secures $156.8m US vaccine deal

The vaccine is marketed under various brand names. Credit: Mathurin NAPOLY / matnapo on Unsplash.

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Deals

Deals July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

Pharmaceutical Business Review

Biocon signs licensing and supply deal for diabetes drug in Brazil

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Popular

  1. ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy
  2. Merck introduces single-use reactor to accelerate ADC manufacturing
  3. Osivax and KM Biologics sign deal for influenza vaccine in Japan
  4. Superluminal Medicines secures $120m in Series A funding round
  5. Moderna’s updated Covid-19 vaccine receives positive EMA CHMP opinion

PRESS RELEASES

Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer Remains on Track in First Half of 2024
Gerresheimer Remains on Track in First Half of 2024
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation